Investor Relations

Founded in 2007, we are a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around the world. From GenHunter, we in-licensed the Trimer-Tag™ technology platform, a product development platform for the creation of novel vaccines. Our mission is to harness transformative science and global partnerships to bring innovative vaccines to populations worldwide.